CC
NAMS icon

Centiva Capital’s NewAmsterdam Pharma NAMS Stock Holding History

Centiva Capital’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
+7,000
New +$231K ﹤0.01% 1307
2026
Q1 		– Sell
-80,000
Closed -$2.81M – 1898
2025
Q4 		$2.81M Buy
+80,000
New +$2.91M 0.02% 373

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Centiva Capital's NAMS Position: Q2 2026 in Review

Centiva Capital opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 7,000 shares worth $237K. The stake represents ﹤0.01% of the portfolio and ranks #1307 among its holdings. This is a return to the name: Centiva Capital previously reported a position in NAMS as recently as Q4 2025.

Centiva Capital first reported a position in NAMS in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.81M in Q4 2025. 195 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Centiva Capital held 7,000 shares of NewAmsterdam Pharma worth $237K as of Q2 2026.
  • NewAmsterdam Pharma was a new Centiva Capital position in Q2 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1307 holding.
  • Centiva Capital first reported a position in NewAmsterdam Pharma in Q4 2025 and has held it in 2 quarters since.
  • Centiva Capital's NewAmsterdam Pharma position peaked at $2.81M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.